REFERENCES
- Lim SA. Ethambutol-associated optic neuropathy. Ann Acad Med Singapore. 2006; 35:274–278.
- Carr RE, Henkind P. Ocular manifestations of ethambutol. Arch Ophthalmol. 1962;67:566–571.
- Sivakumaran P, Harrison AC, Marschener J, Martin P. Ocular toxicity from ethambutol: a review of four cases and recommended precautions. N Z Med. J. 1998 Nov 13;111(1077):428–430.
- Melamud A, Kosmorsky GS, Lee MS. Ocular ethambutol toxicity. Mayo Clin Proc. 2003 Nov; 78(11):1409–1415.
- Polak BC, Leys M, van Lith GH. Blue-yellow color vision changes as early symptoms of ethambutol oculotoxicity. Ophthalmologica. 1985;191(4):223–226.
- Fang JT, Chen YC, Chang MY. Ethambutol-induced optic neuritis in patients with end stage on hemodialysis: two case reports and literature review. Ren Fail. 2004 Mar; 26(2):189–193.
- Citron KM, Thomas GO. Ocular toxicity from ethambutol. Thorax. 1986 Oct;41(10):737–739.
- Barron GJ, Tepper L, Iovine G. Ocular toxicity from ethambutol. Am J Ophthalmol. 1974; 77(2):256–260.
- Fraunfelder FW, Sadun AA, Wood T. Update on ethanol optic neuropathy. Expert Opin Drug Saf. 2006 Sep; 5(5): 615–618.
- Karmon G, Savir H, Zevin D, Levi J. Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment. Ann. Ophthalmol. 1979 Jul; 11(7):1013–1017.
- Kikuchi Hiromi, Hayashi Ryoko, Wakakura Masato. Bitemporal hemianopia-like visual field defect in ethambutol toxic optic neuropathy. Neuro-Ophthal. Japan 2000; 17(3):333–339.
- Lessell S. Histopathology of experimental ethambutol intoxication. Invest Ophthalmol Vis Sci. 1976 Sep; 15(9): 765–769.
- Keigo Shikishima, Kenji Kitahara, Tokihide Mizobuchi, Masaki Yoshida. Interpretation of visual fields defects respecting the vertical meridian and not related to distinct chiasmal or postchiasmal lesion. J Clin Neuroscience. 2006; 13(9):923–928.
- Kozak SF, Inderlied CB, Hsu HY, Heller KB, Sadun AA. The role of copper on ethambutol’s antimicrobial action and implications for ethambutol- induced optic neuropathy. Diagn Microbiol Infect Dis. 1998 Feb; 30(2):83–87.
- Heng JE, Vorwerk CK, Lessell E, Zurakowski D, Levin LA, Drever EB. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. Invest Ophthalmol Vis Sci. 1999 Jan;40(1):190–196.
- Srivastava Ak, Goel UC, Bajaj S, Singh KJ, Dwivedi NC, Tandon MP. Visual evoked responses in ethambutol induced optic neuritis. J Assoc Physicians India. 1997 Nov;45(11):847–849.
- Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2005 May; 243(5):410–416. Epub 2004 Nov 23.
- Kim U, Hwanq JM. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography. Eur J Ophthalmol. 2009 May-Jun;19(3):466–469.
- Salmon JF, Carmichael TR, Welsh NH. Use of contrast sensitivity measurement in detection of subclinical ethambutol optic neuropathy. Br J Ophthalmol. 1987 Mar;71(3):192–196.
- Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1997 Oct;13(5):473–47.
- Chatterjee VK, Buchanan DR, Friedmann AI, Green M. Ocular toxicity following ethambutol in standard dosage. Br J Dis Chest. 1986 Jul;80(3):288–291.
- Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008 Dec; 28(4):269–277.
- Goyal JL, De Sarmi NP, Bhatia A. Evaluation of visual function in patients on ethambutol therapy for tuberculosis: a prospective study. J Commun Dis. 2003 Dec; 35(4):230–243.
- Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1995 Fall; 11(3):411–419.